Getinge AB (Publ) Non-GAAP EPS of SEK2.29
UPDATE 1-US FDA Advises Healthcare Facilities to Switch From Getinge's Heart Devices
Getinge AB's Dividend Analysis
GETINGE AB UNSP ADR EACH REPR 1 ORD To Go Ex-Dividend On April 23rd, 2024 With 0.41639 USD Dividend Per Share
Getinge Acquires Healthmark Industries Co. Inc.
Getinge Recieves FDA Premarket Approval for the ICast Covered Stent System in the US
Getinge AB (publ) Non-GAAP EPS of SEK 2.11, revenue of SEK 6.18B
Getinge AB GAAP EPS of SEK4.54, revenue of SEK7.89B; issues FY22 revenue guidance
Getinge appoints Elin Frostehav as President Acute Care Therapies and Eric Honroth as President Life Science
USD 239.83 mn growth in Extracorporeal Membrane Oxygenation Machines Market | Evolving Opportunities with ALung Technologies Inc & Eurosets Srl | 17000+ Technavio Reports
United States Pharmaceutical Isolators Market Analysis Report 2021 - ResearchAndMarkets.com
Getinge AB reports Q3 results
Ocular Hypertension Market to Witness Robust Expansion at a 3.82% CAGR During the Study Period [2018-2030], Evaluates DelveInsight
No Data
No Data